FDA Approved: MYCOPHENOLIC ACID — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved mycophenolic acid from Biocon Pharma Inc. via an original application. It is indicated to prevent organ transplant rejection in kidney, liver, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Mycophenolic acid (mycophenolic acid)

Snippet

ORIG AP for MYCOPHENOLIC ACID (MYCOPHENOLIC ACID)